Drug Profile
PRX 3140
Alternative Names: NTC-942; PRX-03140; PRX-3140Latest Information Update: 16 Apr 2021
Price :
$50
*
At a glance
- Originator EPIX Pharmaceuticals
- Developer Ology Bioservices
- Class Antidementias; Nootropics; Small molecules
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Post-traumatic stress disorders
Most Recent Events
- 16 Apr 2021 Discontinued - Phase-II for Alzheimer's disease in USA (PO)
- 16 Apr 2021 Discontinued - Phase-II for Post-traumatic stress disorders (In adults) in USA (PO)
- 02 Oct 2017 Nanotherapeutics is now called Ology Bioservices